BioMed X Innovation Center
Im Neuenheimer Feld 515
9 articles with BioMed X Innovation Center
1/16/2020Companies from across the globe provide updates to their business and pipeline.
BioMed X announced the start of a new joint research group in collaboration with Merck.
12/5/2019Companies from across the globe provide updates on their business and pipelines.
BioMed X announced the successful completion of their first joint research project with Boehringer Ingelheim in the fields of chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
BioMed X announced the successful completion of their first research collaboration project with AbbVie in the field of tau-mediated neurodegeneration in Alzheimer’s disease.
9/26/2019Companies from across the globe share updates on their business and pipelines.
BioMed X Successfully Completes Collaboration on Development of Nanomaterial-based Biosensors for Near-patient Testing
BioMed X announced today the completion of their first research collaboration project with Roche Diagnostics in the field of nanomaterial-based biosensors for near patient testing.
For the first time in the successful history of the BioMed X Innovation Center in Heidelberg, its new model based on global crowdsourcing and local incubation of the brightest ideas and talents will now be exposed to a wider audience.
BioMed X and Boehringer Ingelheim Start New Joint Research Group in Bacterial Modulation of Innate Immunity
The focus of the group will be to identify novel regulatory pathways within the innate immune system, through understanding molecular mechanisms employed by bacteria to evade or modulate innate immunity.